DEBRA GIESEN: Open Payments
NPI 1518549229 · WATERBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,189 in 52 payments from 18 companies in 2025. Trend: 2023 $194 · 2024 $1,257 · 2025 $1,189
Food & beverage: $1,173Education: $16
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $234 |
| ABBVIE INC. | 7 | $148 |
| Novo Nordisk Inc | 7 | $146 |
| AstraZeneca Pharmaceuticals LP | 6 | $113 |
| Otsuka America Pharmaceutical, Inc. | 5 | $108 |
| Exact Sciences Corporation | 3 | $79 |
| Astellas Pharma US Inc | 2 | $68 |
| GlaxoSmithKline, LLC. | 2 | $50 |
| Inspire Medical Systems, Inc. | 1 | $33 |
| SANOFI-AVENTIS U.S. LLC | 1 | $33 |
Products named: UBRELVY, MOUNJARO, REXULTI, JARDIANCE, AIRSUPRA, Ozempic, Veozah, SHINGRIX.
Industry payments across CT — which companies pay providers there.
